Specific detection of EGF-EGFR complexes on the cell surface and their dependency on EGFR-directed TKI treatment

Area of Science:

• Oncology
• Molecular Biology
• Cell Biology

Background:

• Epidermal growth factor receptor (EGFR) is crucial in cancer development.
• Understanding EGFR ligand occupancy is limited due to a lack of specific detection tools.
• EGFR's role in tissue homeostasis and tumorigenesis is well-established but ligand binding dynamics are unclear.

Purpose of the Study:

• To develop and utilize a novel reagent, ActE_21, for specifically detecting EGF-bound EGFR.
• To analyze the cell surface levels of EGF-EGFR complexes in human cancer cells.
• To investigate the effect of EGFR-directed tyrosine kinase inhibitors (TKIs) on EGF-EGFR complex localization.

Main Methods:

• Engineered the binder ActE_21 to specifically recognize EGF-bound EGFR.
• Applied ActE_21 to analyze EGF-EGFR complexes on human cancer cell lines (A549, SK-BR3, A431).
• Incubated cells at 37°C and treated with varying EGF concentrations and EGFR-TKIs.

Main Results:

• ActE_21 successfully detected EGF-EGFR complexes on cancer cell surfaces.
• Ligand-induced internalization of EGFR was observed at 37°C.
• Significant amounts of EGF-EGFR complexes remained on the cell surface, increasing with TKI treatment in A549 and SK-BR3 cells, but not A431 cells.

Conclusions:

• A novel method for specifically detecting EGF-EGFR complexes has been established.
• EGFR blockade with TKIs can lead to the accumulation of EGF-bound EGFR on the cell surface in certain cancer types.
• These findings provide new insights into EGFR signaling dynamics and TKI mechanisms of action.